CILODEX OTIC SUSPENSION シンガポール - 英語 - HSA (Health Sciences Authority)

cilodex otic suspension

novartis (singapore) pte ltd - ciprofloxacin hydrochloride eqv to ciprofloxacin; dexamethasone - solution - 0.30% - ciprofloxacin hydrochloride eqv to ciprofloxacin 0.3%; dexamethasone 0.1%

Dexamethasone phosphate ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

dexamethasone phosphate

max health limited - dexamethasone sodium phosphate 4.37 mg/ml equivalent to dexamethasone phosphate 4 mg/ml - solution for injection - 4 mg/ml - active: dexamethasone sodium phosphate 4.37 mg/ml equivalent to dexamethasone phosphate 4 mg/ml excipient: disodium edetate nitrogen propylene glycol sodium hydroxide water for injection - dexamethasone has predominantly glucocorticoid activity and therefore is not a complete replacement therapy in cases of adrenocortical insufficiency. dexamethasone should be supplemented with salt and/or a mineralocorticoid. when so supplemented, dexamethasone is indicated in: · acute adrenocortical insufficiency - addison's disease, bilateral adrenalectomy; · relative adrenocortical insufficiency - prolonged administration of adrenocortical steroids can produce dormancy of the adrenal cortex. the reduced secretory capacity gives rise to a state of relative adrenocortical insufficiency which persists for a varying length of time after therapy is discontinued. should a patient be subjected to sudden stress during this period of reduced secretion (for up to two years after therapy has ceased) the steroid output may not be adequate. steroid therapy should therefore be reinstituted to help cope with stress such as that associated with surgery, trauma, burns, or severe infections where specific antibiotic therapy is available; · primary and secondary adrenocortical insufficiency.

CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) ear drops オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ciloxan ciprofloxacin 3mg/ml (as hydrochloride) ear drops

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - ear drops, solution - excipient ingredients: mannitol; purified water; benzalkonium chloride; sodium hydroxide; disodium edetate; sodium acetate; hydrochloric acid; glacial acetic acid - treatment of chronic suppurative otitis media caused by organisms susceptible to ciprofloxacin in adults and children one month of age or older.

Dicip Ophthalmic Solution ケニア - 英語 - Pharmacy and Poisons Board

dicip ophthalmic solution

unisel pharma (k) ltd 4th parkland avenue, parklands, apricot suites, - ciprofloxacin usp and dexamethasone usp - ophthalmic solution - ciprofloxacin 0.3%w/v & dexamethasone usp 0.1%w/v - ophthalmologicals

Dexamethasone (base) 3.3mg/1ml solution for injection ampoules イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

dexamethasone (base) 3.3mg/1ml solution for injection ampoules

base) 3.3mg/1ml solution for injection ampoules (hameln pharma ltd - dexamethasone sodium phosphate - solution for injection - 3.3mg/1ml

Ciprofloxacin 0.3% / Dexamethasone 0.1% ear drops イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

ciprofloxacin 0.3% / dexamethasone 0.1% ear drops

consilient health ltd - ciprofloxacin hydrochloride; dexamethasone - ear drops - 3mg/1ml ; 1mg/1ml

Ciprofloxacin 0.3% / Dexamethasone 0.1% ear drops イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

ciprofloxacin 0.3% / dexamethasone 0.1% ear drops

a a h pharmaceuticals ltd - ciprofloxacin hydrochloride; dexamethasone - ear drops - 3mg/1ml ; 1mg/1ml

Ciprofloxacin 0.3% / Dexamethasone 0.1% ear drops イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

ciprofloxacin 0.3% / dexamethasone 0.1% ear drops

cst pharma ltd - ciprofloxacin hydrochloride; dexamethasone - ear drops - 3mg/1ml ; 1mg/1ml

Cilodex ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

cilodex

pharmaco (nz) ltd - ciprofloxacin hydrochloride 0.33%{relative} equivalent to 0.3% ciprofloxacin; dexamethasone 1%{relative};   - ear drops - 0.33%/1% - active: ciprofloxacin hydrochloride 0.33%{relative} equivalent to 0.3% ciprofloxacin dexamethasone 1%{relative}   excipient: acetic acid benzalkonium chloride boric acid disodium edetate hydrochloric acid hyetellose purified water sodium acetate trihydrate sodium chloride sodium hydroxide tyloxapol - cilodex is indicated for the topical treatment of acute otitis media in patients with tympanostomy tubes and acute otitis externa in patients caused by strains of bacteria susceptible to ciprofloxacin.

OTOXOLAN EAR DROPS, SUSPENSION FOR DOGS アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

otoxolan ear drops, suspension for dogs

krka, d.d., novo mesto - marbofloxacin, clotrimazole, dexamethasone acetate ph. eur. (equivalent to dexamethasone) - ear drops suspension - 3mg/10mg/1mg - dexamethasone and antiinfectives - canine